Catalyst Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Gyre Therapeutics

15/08/2023 06:27

* Catalyst Biosciences Inc  CBIO.OQ  reported a quarterly
adjusted
loss of 7 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 7 cents
per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Catalyst Biosciences Inc's reported EPS for the quarter
was a
loss of 7 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Catalyst Biosciences Inc shares had fallen by 0.7% this
quarter and gained 6.9% so far this year.
    * The company reported a quarterly loss of $2.47 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 05:27 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.07          -0.07          Met
 Mar. 31 2023      -0.07          0.01           Beat
 Dec. 31 2022      -0.10                         
 Sep. 30 2022      -0.10          -0.16          Missed